Home

Használható Árva küszöbén tia aspirin Transcend egymás maró

NEJM on Twitter: "#VisualAbstract: In patients with minor ischemic stroke  or TIA, aspirin + clopidogrel reduces risk of major ischemic events but  increases risk of major hemorrhage at 90 days than aspirin
NEJM on Twitter: "#VisualAbstract: In patients with minor ischemic stroke or TIA, aspirin + clopidogrel reduces risk of major ischemic events but increases risk of major hemorrhage at 90 days than aspirin

Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download  Table
Efficacy of Clopidogrel-Aspirin Regimen for TIA and Minor Stroke | Download Table

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin  in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke
Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack | Stroke

Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke
Medical therapies (Chapter 24) - Transient Ischemic Attack and Stroke

Antiplatelet Therapy for Secondary Stroke Prevention in Patients with  Ischemic Stroke or Transient Ischemic Attack
Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack

Contraindications to aspirin in suspected TIA | Download Table
Contraindications to aspirin in suspected TIA | Download Table

Abbreviations: ACS indicates acute coronary syndrome; TIA, transient... |  Download Scientific Diagram
Abbreviations: ACS indicates acute coronary syndrome; TIA, transient... | Download Scientific Diagram

Immediate aspirin after mini-stroke substantially reduces risk of major  stroke | University of Oxford
Immediate aspirin after mini-stroke substantially reduces risk of major stroke | University of Oxford

THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA |  tctmd.com
THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA | tctmd.com

Antithrombotic therapies (Chapter 18) - The Stroke Book
Antithrombotic therapies (Chapter 18) - The Stroke Book

THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs
THALES Secondary Efficacy | BRILINTA® (ticagrelor) tablets | For HCPs

Dual antiplatelet therapy with ticagrelor may increase the risk of all  bleeding events in patients with minor strokes or high risk TIAs: a  meta-analysis | Stroke and Vascular Neurology
Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis | Stroke and Vascular Neurology

A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients  after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM
A Comparison of Two Doses of Aspirin (30 mg vs. 283 mg a Day) in Patients after a Transient Ischemic Attack or Minor Ischemic Stroke | NEJM

Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient  Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke
Dual Antiplatelet Therapy Versus Aspirin in Patients With Stroke or Transient Ischemic Attack: Meta-Analysis of Randomized Controlled Trials | Stroke

Blogging Stroke – Role of Combined Clopidogrel and Aspirin in High-Risk TIA  and Stroke: Discussing the POINT Trial
Blogging Stroke – Role of Combined Clopidogrel and Aspirin in High-Risk TIA and Stroke: Discussing the POINT Trial

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

Current Recommendations for Secondary Stroke Prevention
Current Recommendations for Secondary Stroke Prevention

Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA |  Semantic Scholar
Clopidogrel and Aspirin in Acute Ischemic Stroke and High‐Risk TIA | Semantic Scholar

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute  Ischemic Stroke or Transient Ischemic Attack | Neurology
Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack | Neurology

Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA  Patients Better than Aspirin Alone - Physician's Weekly
Dual Antiplatelet Therapy Lowers Stroke, Death Rates in Ischemic Stroke/TIA Patients Better than Aspirin Alone - Physician's Weekly

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient  Ischemic Attack of Atherosclerotic Origin | Stroke
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke

Antithrombotic therapy by cause of TIA - UpToDate
Antithrombotic therapy by cause of TIA - UpToDate

Stroke Guidelines | The International Aspirin Foundation
Stroke Guidelines | The International Aspirin Foundation

Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in  Noncardioembolic Transient Ischemic Attack or Stroke | Stroke
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke | Stroke

The THALES Trial: Ticagrelor and Aspirin vs Aspirin Alone in Acute Ischemic  Stroke or TIA - REBEL EM - Emergency Medicine Blog
The THALES Trial: Ticagrelor and Aspirin vs Aspirin Alone in Acute Ischemic Stroke or TIA - REBEL EM - Emergency Medicine Blog